War on Cancer 3.0
Hosted by STAT in partnership with The Jackson Laboratory
Scientists are learning to manipulate the body’s immune response to mount targeted attacks on cancer cells. At the same time, genomic and other advances have given cancer doctors new tools to more precisely characterize individual tumor cells and the mutations driving cancers, opening up a range of new treatment options, including CAR-T therapies, neoantigen vaccines, and kinase inhibitors. This panel of leading cancer experts will explore what’s ahead in cancer treatment.
Having trouble deciding on just one event? Try the Insider Pass